Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
22.2M
-
Number of holders
-
184
-
Total 13F shares, excl. options
-
13.3M
-
Shares change
-
+1.56M
-
Total reported value, excl. options
-
$3.86B
-
Value change
-
+$563M
-
Put/Call ratio
-
1.9
-
Number of buys
-
128
-
Number of sells
-
-59
-
Price
-
$290.25
Significant Holders of MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) as of Q4 2022
243 filings reported holding MDGL - MADRIGAL PHARMACEUTICALS, INC. - Common Stock as of Q4 2022.
MADRIGAL PHARMACEUTICALS, INC. - Common Stock (MDGL) has 184 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.3M shares
of 22.2M outstanding shares and own 59.83% of the company stock.
Largest 10 shareholders include Avoro Capital Advisors LLC (1.66M shares), BAKER BROS. ADVISORS LP (1.55M shares), VANGUARD GROUP INC (1.27M shares), STATE STREET CORP (1.26M shares), BlackRock Inc. (987K shares), PERCEPTIVE ADVISORS LLC (732K shares), Avidity Partners Management LP (430K shares), Rock Springs Capital Management LP (348K shares), TCG Crossover Management, LLC (288K shares), and GEODE CAPITAL MANAGEMENT, LLC (237K shares).
This table shows the top 184 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.